Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6910
+0.0035 (0.51%)
Apr 21, 2026, 10:55 AM EDT - Market open
Humacyte Stock Forecast
HUMA's stock price has decreased by -59.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts that cover Humacyte stock have a consensus rating of "Strong Buy" and an average price target of $6.19, which forecasts a 795.80% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $25.
Price Target: $6.19 (+795.80%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Humacyte stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $3.5 → $1.5 | Buy | Maintains | $3.5 → $1.5 | +117.08% | Apr 8, 2026 |
| Benchmark | Benchmark | Strong Buy → Buy Downgrades $10 → $1 | Strong Buy → Buy | Downgrades | $10 → $1 | +44.72% | Mar 31, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $3 → $1 | Hold | Maintains | $3 → $1 | +44.72% | Mar 30, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $1 | Strong Buy | Maintains | $3.5 → $1 | +44.72% | Mar 30, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +3,517.95% | Mar 27, 2026 |
Financial Forecast
Revenue This Year
12.77M
from 2.04M
Increased by 526.55%
Revenue Next Year
38.64M
from 12.77M
Increased by 202.58%
EPS This Year
-0.43
from -0.26
EPS Next Year
-0.33
from -0.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 22.9M | 51.7M | |||
| Avg | 12.8M | 38.6M | |||
| Low | 6.9M | 26.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1,023.2% | 304.6% | |||
| Avg | 526.5% | 202.6% | |||
| Low | 236.6% | 103.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.36 | -0.28 | |||
| Avg | -0.43 | -0.33 | |||
| Low | -0.51 | -0.40 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.